FDA — authorised 18 October 1978
- Application: NDA017923
- Marketing authorisation holder: NOVARTIS
- Local brand name: MELLARIL-S
- Indication: SUSPENSION — ORAL
- Status: approved
FDA authorised Mellaril on 18 October 1978
Yes. FDA authorised it on 18 October 1978.
NOVARTIS holds the US marketing authorisation.